Phase 3 COPD clinical trials

13 recruiting Phase 3 copd studies in the US. What trial phases mean

Other phases

RecruitingPhase 3NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Chandler, AZ · Phoenix, AZ · Surprise, AZ · +72 more sites

RecruitingPhase 3NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Sponsor: AstraZeneca

Birmingham, AL · Cullman, AL · Phoenix, AZ · +77 more sites

RecruitingPhase 3NCT06959095

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Sponsor: GlaxoSmithKline

Bakersfield, CA · Modesto, CA · Newport Beach, CA · +39 more sites

RecruitingPhase 3NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Sponsor: GlaxoSmithKline

Sheffield, AL · Aurora, CO · Brooksville, FL · +54 more sites

RecruitingPhase 3NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Athens, AL · Cullman, AL · Fairhope, AL · +232 more sites

RecruitingPhase 3NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Sponsor: Sanofi

Birmingham, AL · Mobile, AL · Tucson, AZ · +73 more sites

RecruitingPhase 3NCT07780656

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Sponsor: GlaxoSmithKline

Miami, FL · Tampa, FL · Rapid City, SD · +1 more sites

RecruitingPhase 3NCT07793409

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

Sponsor: Sanofi

Newport Beach, CA · Boynton Beach, FL

RecruitingPhase 3NCT07780669

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

Sponsor: GlaxoSmithKline

Doral, FL · Lake Charles, LA

RecruitingPhase 3NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Sponsor: AstraZeneca

Foley, AL · Mobile, AL · Sheffield, AL · +70 more sites

RecruitingPhase 3NCT06376994

Multi-Center Clean Air Randomized Controlled Trial in COPD

Sponsor: JHSPH Center for Clinical Trials

Birmingham, AL · Los Angeles, CA · Iowa City, IA · +8 more sites

RecruitingPhase 3NCT07177339

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Sponsor: GlaxoSmithKline

Newport Beach, CA · Lakewood, CO · Brandon, FL · +39 more sites

RecruitingPhase 3NCT05265299

Trial to Determine Effective Aspirin Dose in COPD

Sponsor: Johns Hopkins University

Baltimore, MD

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.